Govan JR[au] - Search Results

Year	Number of Results
1946	3
1947	1
1949	1
1950	1
1953	1
1966	1
1968	1
1969	1
1973	1
1974	2
1975	1
1976	1
1977	1
1978	1
1979	1
1980	1
1981	1
1983	1
1984	2
1985	1
1986	4
1987	2
1988	2
1989	2
1990	5
1991	1
1992	6
1993	5
1994	3
1995	4
1996	5
1997	2
1998	6
1999	7
2000	6
2001	6
2002	6
2003	7
2004	7
2005	6
2006	4
2007	6
2008	5
2009	6
2010	8
2011	3
2012	3
2013	5
2014	2
2017	1
2018	1
2022	0

1

Virulence factors of Burkholderia cepacia.

Nelson JW, Butler SL, Krieg D, Govan JR. Nelson JW, et al. Among authors: govan jr. FEMS Immunol Med Microbiol. 1994 Feb;8(2):89-97. doi: 10.1111/j.1574-695X.1994.tb00430.x. FEMS Immunol Med Microbiol. 1994. PMID: 7513590 Review. No abstract available.

2

Chemical and biological features of Burkholderia cepacia complex lipopolysaccharides.

De Soyza A, Silipo A, Lanzetta R, Govan JR, Molinaro A. De Soyza A, et al. Among authors: govan jr. Innate Immun. 2008 Jun;14(3):127-44. doi: 10.1177/1753425908093984. Innate Immun. 2008. PMID: 18562572 Free article. Review.

3

Microbiology of lung infection in cystic fibrosis.

Govan JR, Nelson JW. Govan JR, et al. Br Med Bull. 1992 Oct;48(4):912-30. doi: 10.1093/oxfordjournals.bmb.a072585. Br Med Bull. 1992. PMID: 1281036 Review.

4

Pathogenicity of microbes associated with cystic fibrosis.

Hutchison ML, Govan JR. Hutchison ML, et al. Among authors: govan jr. Microbes Infect. 1999 Oct;1(12):1005-14. doi: 10.1016/s1286-4579(99)80518-8. Microbes Infect. 1999. PMID: 10617932 Review.

5

Taxonomy and identification of the Burkholderia cepacia complex.

Coenye T, Vandamme P, Govan JR, LiPuma JJ. Coenye T, et al. Among authors: govan jr. J Clin Microbiol. 2001 Oct;39(10):3427-36. doi: 10.1128/JCM.39.10.3427-3436.2001. J Clin Microbiol. 2001. PMID: 11574551 Free PMC article. Review. No abstract available.

6

Burkholderia cepacia: medical, taxonomic and ecological issues.

Govan JR, Hughes JE, Vandamme P. Govan JR, et al. J Med Microbiol. 1996 Dec;45(6):395-407. doi: 10.1099/00222615-45-6-395. J Med Microbiol. 1996. PMID: 8958242 Review.

7

Evolving epidemiology of Pseudomonas aeruginosa and the Burkholderia cepacia complex in cystic fibrosis lung infection.

Govan JR, Brown AR, Jones AM. Govan JR, et al. Future Microbiol. 2007 Apr;2(2):153-64. doi: 10.2217/17460913.2.2.153. Future Microbiol. 2007. PMID: 17661652 Review.

8

Microbiology of cystic fibrosis lung infections: themes and issues.

Govan JR, Nelson JW. Govan JR, et al. J R Soc Med. 1993;86 Suppl 20(Suppl 20):11-8. J R Soc Med. 1993. PMID: 7684788 Free PMC article. Review. No abstract available.

9

Pseudomonas serology: confusion, controversy, and challenges.

Farrell PM, Govan JR. Farrell PM, et al. Among authors: govan jr. Thorax. 2006 Aug;61(8):645-7. doi: 10.1136/thx.2006.062612. Epub 2006 Jun 12. Thorax. 2006. PMID: 16769714 Free PMC article.

10

Rational parameters for antibiotic therapy in patients with cystic fibrosis.

Govan JR, Doherty C, Glass S. Govan JR, et al. Infection. 1987 Jul-Aug;15(4):300-7. doi: 10.1007/BF01644142. Infection. 1987. PMID: 3117704 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results